Perioperative management with phosphodiesterase type 5 inhibitor and prostaglandin E1 for moderate portopulmonary hypertension following adult-to-adult living-donor liver transplantation: a case report

BACKGROUND: Portopulmonary hypertension (PPH) is a relatively rare but well-recognized complication of end-stage liver disease. Moderate or severe PPH (mean pulmonary artery pressure [mPAP] ≥ 35 mmHg) is usually a contraindication for liver transplantation due to high operation-related mortality. He...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Surg Case Rep
Egile Nagusiak: Onoe, Takashi, Tanaka, Asuka, Ishiyama, Kohei, Ide, Kentaro, Tashiro, Hirotaka, Ohdan, Hideki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2018
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5803166/
https://ncbi.nlm.nih.gov/pubmed/29417353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-018-0423-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak